Bayer Yakuhin Ltd., Japan

Name

Bayer Yakuhin Ltd., Japan

Legal name

Bayer Yakuhin, Ltd.

Website

https://bayer.jp

Company type

Private

Founded year

1973

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Bayer Yakuhin Ltd. is the Japanese pharmaceutical operating subsidiary of Germany's Bayer AG, selling prescription drugs across cardiovascular, oncology, ophthalmology, gynecology, hematology, and radiology, alongside Bayer Consumer Health OTC products and Bayer CropScience agrochemicals and digital farming solutions in Japan.

Ownership category

akta.pro rank

Product category

Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing (3253)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Vaccines & Cold-Chain Pharmaceutical Distributors (HLAIAJAG)

akta.pro secondary industry

Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience) (CRAOAHAG)

Keywords

• Prescription pharmaceuticals
• Consumer health products
• Crop protection chemicals
• Life sciences solutions
• Agricultural sciences

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices6 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Pharmaceuticals: Development, import, manufacture and sales of prescription pharmaceuticals and medical devices in Japan
2. Consumer Health: Over-the-counter medications, nutritional supplements, and wellness products distributed through retail channels
3. Crop Science: Development, manufacture, import, export, and sales of agrochemicals, quarantine chemicals, and agricultural digital solutions

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Bayer Yakuhin is the Japanese pharmaceutical operating subsidiary of Bayer AG, engaged in the development, import, manufacture, and sales of prescription pharmaceuticals and medical devices; the marketing of over-the-counter consumer health products including women's health supplements, aspirin-based analgesics, and allergy treatments; and through affiliated Bayer CropScience K.K., the manufacture, import, and sale of agrochemicals, seed treatments, and digital agriculture solutions including drone-based services. The business operates three main divisions — Pharmaceuticals, Consumer Health, and Crop Science — supported by manufacturing facilities in Shiga and Hofu and R&D centers in Ibaraki and Kochi.

Product overview

Bayer Yakuhin Ltd., Japan operates as part of the Bayer Group, a global life science company focused on healthcare and agriculture. The Japanese operations consist of a holding company structure with three main business divisions: Pharmaceuticals (バイエル약품) handling prescription medicines across cardiovascular, oncology, ophthalmology, gynecology, hematology, and diagnostic imaging; Consumer Health (コンシューマーヘルス) offering OTC products including aspirin-based analgesics, allergy treatments, and women's health supplements; and Crop Science (バイエルクロップサイエンス) providing agrochemicals (insecticides, fungicides, herbicides, seed treatments) and digital agriculture solutions including drone services. Subsidiaries include Bayer Holding Ltd. (holding company), Bayer Yakuhin Ltd. (pharmaceuticals), Bayer CropScience K.K. (crop protection), and Bayer Life Science Co., Ltd. (pharmaceutical manufacturing). The company operates manufacturing facilities in Shiga (pharmaceuticals) and Hofu (agrochemicals), plus a development center in Yuki, Ibaraki.

Differentiator

Problem solved

Functional benefit

Brands

• Bayer Pharmaceuticals: Healthcare division focusing on pharmaceuticals — includes cardiovascular/renal, oncology, ophthalmology, women's health, hematology, and radiology.
• Bayer Consumer Health
• Bayer CropScience

Products and services

• Pharmaceuticals (医療用医薬品) Provides prescription pharmaceuticals across cardiovascular and kidney diseases, oncology (liver cancer, colorectal cancer, prostate cancer), hematology (hemophilia treatments with recombinant blood clotting factor VIII), ophthalmology (treatments for wet age-related macular degeneration), gynecology (endometriosis, dysmenorrhea, heavy menstrual bleeding, menopausal disorders, contraception), and diagnostic imaging (contrast agents and injectors for X-ray, CT, MRI, and ultrasound). Targets Japanese hospitals, clinics, and prescribing physicians.
• Consumer Health (コンシューマーヘルス) Over-the-counter consumer health products including nutritional supplements for women's health from preconception through postpartum and breastfeeding, aspirin-based analgesic (Bayer Aspirin, with over 110 years of history), allergy treatments, and antifungal treatments for vaginal candidiasis. Targeted at individual Japanese consumers through retail pharmacy distribution.
• Crop Science (クロップサイエンス) Agrochemical products including insecticides, fungicides, herbicides, and seed treatment agents, with global R&D capabilities. Also provides drone business services and digital technology solutions for sustainable agriculture development in Japan. Targets Japanese farmers and agricultural cooperatives.

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Daiichi Sankyo HealthcarecoreStrategic or Co-development Partner · 15 July 2026Bayer Yakuhin and Daiichi Sankyo Healthcare entered into a licensing agreement for Claritin EX (クラリチン®EX), expanding consumer health product offerings in Japan.

Scale indicators4 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Eisai Co., Ltd. Japanese pharma with major oncology and neurology franchises. Competes with Bayer Yakuhin in oncology and operates similar domestic direct sales and consumer health adjacencies, with strong brand recognition comparable to Bayer's Aspirin heritage.
• Taisho Pharmaceutical Co., Ltd. Japanese consumer health and OTC-focused pharmaceutical company. Directly comparable to Bayer's Consumer Health division in OTC analgesics, allergy, and women's health supplements distributed through Japanese retail pharmacy channels.
• Shionogi & Co., Ltd. Mid-cap Japanese pharmaceutical company with significant presence in women's health, infectious disease, and pain. Directly overlaps Bayer Yakuhin's gynecology and analgesic (Aspirin) franchises in Japan.
• Sumitomo Chemical Company, Limited: Major Japanese chemical and agrochemical company with crop protection and pharmaceuticals operations. Highly comparable to Bayer CropScience Japan's agrochemical and pesticide manufacturing footprint (Hofu-equivalent facilities).
• Otsuka Pharmaceutical Co., Ltd. Diversified Japanese pharma with material consumer health and women's health adjacencies. Comparable in OTC/nutraceutical strategy and prescription pharma in cardiology and oncology, with strong domestic distribution.
• Chugai Pharmaceutical Co., Ltd. Roche-majority-owned Japanese pharma with strong oncology, renal, and specialty pipeline. Highly comparable structure as a Japanese subsidiary of a global pharma parent, with similar model of importing and registering global pipeline products in Japan.
• Takeda Pharmaceutical Company Limited: Japan's largest pharmaceutical company and a former joint venture partner with Bayer in Bayer Yakuhin (1973). Operates across prescription pharmaceuticals, rare diseases, and consumer health with similar therapeutic area overlap (cardiovascular, oncology, gynecology), making it the most directly comparable Japanese pharma peer.
• Astellas Pharma Inc. Leading Japanese pharmaceutical company with strong franchises in oncology, urology, and women's health — categories where Bayer Yakuhin also competes (prostate cancer, gynecology, endocrinology). Comparable Japan-focused go-to-market via direct medical representative sales.
• Daiichi Sankyo Company, Limited: Major Japanese pharmaceutical company with overlapping prescription drug portfolio in cardiovascular and oncology. Strategic partner of Bayer Yakuhin via the Claritin EX licensing deal, making it both a competitor and an active commercial counterpart.

Broad incumbents

• Sanofi K.K. (Japan): Japanese subsidiary of global pharma major Sanofi. Comparable as another global pharma's Japanese subsidiary with three-division structure (specialty care, vaccines, consumer health) and direct sales to Japanese healthcare providers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bayer Yakuhin Ltd., Japan